Discounting the efficacy of sulodexide in diabetic nephropathy is premature

Comment

Giovanni Gambaro. Am J Kidney Dis. 2012 Jul.

. 2012 Jul;60(1):169-70.

doi: 10.1053/j.ajkd.2012.01.029.

No abstract available

Comment on

Sulodexide for kidney protection in type 2 diabetes patients with microalbuminuria: a randomized controlled trial.
Lewis EJ, Lewis JB, Greene T, Hunsicker LG, Berl T, Pohl MA, de Zeeuw D, Heerspink HL, Rohde RD, Atkins RC, Reutens AT, Packham DK, Raz I; Collaborative Study Group. Lewis EJ, et al. Am J Kidney Dis. 2011 Nov;58(5):729-36. doi: 10.1053/j.ajkd.2011.06.020. Epub 2011 Aug 26. Am J Kidney Dis. 2011. PMID: 21872376 Clinical Trial.
Sulodexide for diabetic nephropathy: another one bites the dust.
House AA, Weir MA. House AA, et al. Am J Kidney Dis. 2011 Nov;58(5):692-4. doi: 10.1053/j.ajkd.2011.08.011. Am J Kidney Dis. 2011. PMID: 22014634 No abstract available.